Christoph Nitsche is Associate Professor and ARC Future Fellow at the Australian National University (ANU) in Canberra. He completed his PhD at Heidelberg University in 2014 and received a Feodor Lynen Fellowship by the Alexander von Humboldt Foundation to work at the ANU from 2015 to 2018. He received an ARC Discovery Early Career Research Award in 2019 and was appointed to a tenured faculty position at ANU in 2020. He is the recipient of the John Wade Early Career Researcher Award (2022), the Peter Schwerdtfeger Award (2022), the RSC Medicinal Chemistry Emerging Investigator Lectureship (2023), the Rennie Memorial Medial (2023) and the Peter Andrews Award for Innovation in Medicinal Chemistry and Chemical Biology (2025). He was named the top Australian researcher in Medicinal Chemistry by ’The Australian’ for 2023, 2024 and 2025. His research program focuses on the biocompatible modification of peptides and proteins to advance drug discovery for infectious diseases and the development of theranostic agents.